Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

Bullboard (TSX:TH)

View:
Comment by Trogarzonon Jun 01, 2024 10:25am

RE:Progression free survival rate

Do we have something on their posters... something like those compelling news that could make us richer than 40 cents....
Post by scarlet1967on Jun 01, 2024 9:40am

Progression free survival rate

    This bispecific antibody stops immunosuppression and blood supply process both responsible for progression of the cancer. The drug is now approved in combo therapy for cancer in ...more  
Post by Trogarzonon May 31, 2024 4:04pm

Pouet Pouet week again

Tomorrow ASCO..  last call for a partner and another dilution... Q2 sales should be good... lol...
Post by CreatingApeon May 30, 2024 3:46pm

Wino?

I understand why you have been taking a break from this board. Trust me. But are you still in this with us? Miss all of your input, hope you are well and that you are just avoiding this messaging ...more  
Post by Jonathon Brownon May 30, 2024 5:01am

Buzz on the Bullboards: Volatility persists in the face of economic indicators

Comment by Trogarzonon May 28, 2024 12:33pm

RE:RE:RE:Market does know how to value biotech companies. See below

Most second hand opinions I get from  onco specialists is that the revised protocol will probably yield much better efficacity.  The odds are on our side it seems.
Comment by Momo25on May 28, 2024 11:28am

RE:RE:Market does know how to value biotech companies. See below

Maybe the market got it wrong with Thera because it is hard to get it right with this kind of management.  Anyway, what I try to say is don't be so excited with the current outcome, we don ...more  
Comment by Trogarzonon May 28, 2024 8:55am

RE:Market does know how to value biotech companies. See below

Just saying the market got it wrong with Thera in 2010, 2014 and 2018... by a mile. Taling 20 cents to 15$ wrong.  
Post by Momo25on May 27, 2024 11:56pm

Market does know how to value biotech companies. See below

The Best Biotech Stocks of May 2024 Company (TICKER) 5-Year Average Annual EPS Forecast  ...more  
Comment by Mannequinon May 27, 2024 6:31pm

RE:RE:ASCO Info

I had my contact at GSK put a recent phase two result through my AI model this AM and it said it was not good enough to move forward - and that is the case in their phase 2 example. So it's pretty ...more  
Comment by Qwerty54321on May 27, 2024 5:27pm

RE:ASCO Info

One thing the AI didn't pick up is the analysis is for a SUBSET of all treated patient. I'm not going to go back and check the PR but it's something like 3 "women's" cancers, ...more  
Comment by Trogarzonon May 27, 2024 2:51pm

RE:It's about trust

In the mean time the market as you call it with all it's mighty intelligencia (the market is always wright the saying goes) buys Trump media and Gamestop.  Apart from our dear management ...more  
Post by Momo25on May 27, 2024 2:46pm

It's about trust

Th management and the CEO have overwhelmigly lied in the past so nobody trust them anymore. Hence, whatever the results might be of interest they are not making the market moving to the right ...more  
Post by Mannequinon May 27, 2024 8:09am

AI Conclusion of Abstract

### Interpretation and Considerations   1. **Efficacy:**    - The stabilization of disease in a heavily pretreated population, along with a partial response and complete response ...more  
Post by Mannequinon May 27, 2024 8:04am

ASCO Info

I let the most advanced AI that I have access to review several ASCO abstracts from other companies. It concluded that these other companies were not really getting the results necessary in the ...more  
Comment by Mannequinon May 26, 2024 2:26pm

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

It is sad it potentially could have helped, and I wonder if anyone else in her situation has been put through the program with ovarian cancer and seen any benefit. There is not much explained thus far ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities